PlainRecalls
FDA Devices Moderate Class II Ongoing

Propel Mini Mometasone Furoate Sinus Implant, with Straight Delivery System, REF 60044

Reported: December 14, 2022 Initiated: October 21, 2022 #Z-0458-2023

Product Description

Propel Mini Mometasone Furoate Sinus Implant, with Straight Delivery System, REF 60044

Reason for Recall

Sinus Implant product label displays incorrect product information including: "Straight Delivery System", with incorrect reference number and UDI-DI.

Details

Recalling Firm
Intersect ENT, Inc.
Units Affected
611 units
Distribution
US Nationwide distribution including in the states of NC, IL, KS, OR, WI, TX, FL, MN, WY, UT, NY, CA, NJ, OK, MD, HI, MT, TN, MO, IA, MA, AZ, GA, LA, ID, SC, WA, SD, ND, CO, NV.
Location
Menlo Park, CA

Frequently Asked Questions

What product was recalled?
Propel Mini Mometasone Furoate Sinus Implant, with Straight Delivery System, REF 60044. Recalled by Intersect ENT, Inc.. Units affected: 611 units.
Why was this product recalled?
Sinus Implant product label displays incorrect product information including: "Straight Delivery System", with incorrect reference number and UDI-DI.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 14, 2022. Severity: Moderate. Recall number: Z-0458-2023.